sixty patients , 30 with depressive neurosis , 15 with anxiety neurosis and 15 with phobic anxiety states , were treated with the monoamine oxidase inhibitor , phenelzine , in two different dosage schedules for four weeks .
C0011581
depressive neurosis
C0031392
phenelzine